文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

英国生物库中体重指数与心脏代谢疾病的关联:一项孟德尔随机化研究。

Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.

机构信息

Institute of Health & Wellbeing, University of Glasgow, Glasgow, Scotland.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Scotland.

出版信息

JAMA Cardiol. 2017 Aug 1;2(8):882-889. doi: 10.1001/jamacardio.2016.5804.


DOI:10.1001/jamacardio.2016.5804
PMID:28678979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5710596/
Abstract

IMPORTANCE: Higher body mass index (BMI) is a risk factor for cardiometabolic disease; however, the underlying causal associations remain unclear. OBJECTIVES: To use UK Biobank data to report causal estimates of the association between BMI and cardiometabolic disease outcomes and traits, such as pulse rate, using mendelian randomization. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional baseline data from a population-based cohort study including 119 859 UK Biobank participants with complete phenotypic (medical and sociodemographic) and genetic data. Participants attended 1 of 22 assessment centers across the United Kingdom between 2006 and 2010. The present study was conducted from May 1 to July 11, 2016. MAIN OUTCOMES AND MEASURES: Prevalence of hypertension, coronary heart disease, and type 2 diabetes were determined at assessment, based on self-report. Blood pressure was measured clinically. Participants self-reported sociodemographic information pertaining to relevant confounders. A polygenic risk score comprising 93 single-nucleotide polymorphisms associated with BMI from previous genome-wide association studies was constructed, and the genetic risk score was applied to derive causal estimates using a mendelian randomization approach. RESULTS: Of the 119 859 individuals included in the study, 56 816 (47.4%) were men; mean (SD) age was 56.87 (7.93) years. Mendelian randomization analysis showed significant positive associations between genetically instrumented higher BMI and risk of hypertension (odds ratio [OR] per 1-SD higher BMI, 1.64; 95% CI, 1.48-1.83; P = 1.1 × 10-19), coronary heart disease (OR, 1.35; 95% CI, 1.09-1.69; P = .007) and type 2 diabetes (OR, 2.53; 95% CI, 2.04-3.13; P = 1.5 × 10-17), as well as systolic blood pressure (β = 1.65 mm Hg; 95% CI, 0.78-2.52 mm Hg; P = 2.0 × 10-04) and diastolic blood pressure (β  = 1.37 mm Hg; 95% CI, 0.88-1.85 mm Hg; P = 3.6 × 10-08). These associations were independent of age, sex, Townsend deprivation scores, alcohol intake, and smoking history. CONCLUSIONS AND RELEVANCE: The results of this study add to the burgeoning evidence of an association between higher BMI and increased risk of cardiometabolic diseases. This finding has relevance for public health policies in many countries with increasing obesity levels.

摘要

重要提示:较高的体重指数(BMI)是心血管代谢疾病的危险因素;然而,其潜在的因果关系仍不清楚。

目的:利用英国生物库的数据,采用孟德尔随机化报告 BMI 与心血管代谢疾病结局以及脉搏率等特征之间的因果关联的估计值。

设计、地点和参与者:本研究为一项基于人群的队列研究的横断面基线数据,纳入了 119859 名具有完整表型(医疗和社会人口统计学)和遗传数据的英国生物库参与者。参与者于 2006 年至 2010 年间在英国的 22 个评估中心中的 1 个参加了评估。本研究于 2016 年 5 月 1 日至 7 月 11 日进行。

主要结局和测量指标:根据自我报告,在评估时确定高血压、冠心病和 2 型糖尿病的患病率。血压通过临床测量。参与者自我报告了与相关混杂因素有关的社会人口统计学信息。构建了一个由 93 个单核苷酸多态性组成的多基因风险评分,这些单核苷酸多态性与之前的全基因组关联研究中的 BMI 相关,采用孟德尔随机化方法应用遗传风险评分来推导出因果估计值。

结果:在纳入的 119859 名个体中,56816 名(47.4%)为男性;平均(标准差)年龄为 56.87(7.93)岁。孟德尔随机化分析显示,较高的 BMI 与高血压(每增加 1-SD BMI 的比值比[OR],1.64;95%CI,1.48-1.83;P = 1.1×10-19)、冠心病(OR,1.35;95%CI,1.09-1.69;P = .007)和 2 型糖尿病(OR,2.53;95%CI,2.04-3.13;P = 1.5×10-17)风险呈显著正相关,还与收缩压(β=1.65mmHg;95%CI,0.78-2.52mmHg;P = 2.0×10-04)和舒张压(β=1.37mmHg;95%CI,0.88-1.85mmHg;P = 3.6×10-08)呈正相关。这些关联独立于年龄、性别、汤森剥夺评分、饮酒量和吸烟史。

结论和相关性:本研究结果增加了较高 BMI 与心血管代谢疾病风险增加之间存在关联的证据。这一发现与许多肥胖水平不断上升的国家的公共卫生政策有关。

相似文献

[1]
Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.

JAMA Cardiol. 2017-8-1

[2]
Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.

JAMA. 2017-2-14

[3]
A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.

Lancet Digit Health. 2019-7

[4]
Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study.

Int J Epidemiol. 2019-10-1

[5]
Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study.

PLoS Med. 2019-12-10

[6]
Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank.

Sleep. 2019-3-1

[7]
Blood Pressure and Risk of Cardiovascular Disease in UK Biobank: A Mendelian Randomization Study.

Hypertension. 2021-2

[8]
Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.

PLoS Med. 2021-3

[9]
Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.

Eur Heart J. 2020-1-7

[10]
Metabolic and lifestyle factors in relation to senile cataract: a Mendelian randomization study.

Sci Rep. 2022-1-10

引用本文的文献

[1]
Genetic Variants in Metabolic Pathways and Their Role in Cardiometabolic Risk: An Observational Study of >4000 Individuals.

Biomedicines. 2025-7-22

[2]
Cardiovascular Health Metrics, Genetic Susceptibility, and Incident Chronic Obstructive Pulmonary Disease: A Prospective Cohort Analysis.

JACC Adv. 2025-7-16

[3]
Interaction of genetic risk score (GRS) and Plant-Based diet on atherogenic factors and body fat distribution indices among women with overweight and obesity: a cross-sectional study.

Sci Rep. 2025-7-8

[4]
Unraveling the influence of body mass index on complex diseases in East Asians: Insights from Mendelian randomization phenome-wide association study.

Medicine (Baltimore). 2025-6-27

[5]
GDF15: An emerging disease target and biomarker of metabolic diseases.

J Endocrinol Invest. 2025-6-26

[6]
The Genetic Elements of the Obesity Paradox in Atherosclerosis Identified in an Intercross Between Hyperlipidemic Mouse Strains.

Int J Mol Sci. 2025-4-29

[7]
Genetic predisposition to adiposity, and type 2 diabetes: the role of lifestyle and phenotypic adiposity.

Eur J Endocrinol. 2025-4-30

[8]
The Impact of Exercise Training in a Hypobaric/Normobaric Hypoxic Environment on Cardiometabolic Health in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.

Life (Basel). 2025-3-31

[9]
A Complex Network of Obesity-Risk Genes Revealed by Systematic Bioinformatics and Single-Cell Transcriptomic Analyses.

J Obes. 2025-3-31

[10]
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillation.

Front Cardiovasc Med. 2025-3-4

本文引用的文献

[1]
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.

JAMA Cardiol. 2016-9-1

[2]
Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 Participants.

PLoS One. 2016-4-25

[3]
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.

Int J Epidemiol. 2015-4

[4]
The epidemiology of cardiovascular disease in the UK 2014.

Heart. 2015-8

[5]
Adiposity as a cause of cardiovascular disease: a Mendelian randomization study.

Int J Epidemiol. 2015-4

[6]
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

PLoS Med. 2015-3-31

[7]
Genetic studies of body mass index yield new insights for obesity biology.

Nature. 2015-2-12

[8]
Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.

Am J Med. 2014-10-15

[9]
Mendelian randomization: genetic anchors for causal inference in epidemiological studies.

Hum Mol Genet. 2014-9-15

[10]
Obesity, hypertension, and chronic kidney disease.

Int J Nephrol Renovasc Dis. 2014-2-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索